abstract |
The present invention relates to substituted xanthines of the general formula in the R are as defined in claim 1, their tautomers, their stereoisomers, their mixtures and their salts, which have valuable pharmacological properties, in particular an inhibitory effect on the activity of the enzyme dipeptidyl peptidase-IV (DPP-IV). |